ClearSign grants director Basenese 3,766 options

The award was immediately vested and exercisable, with a $3.55 exercise price and a September 29, 2036 expiration.

Rhea-AI Filing Summary

ClearSign Technologies Corp director Lou Basenese received a grant of 3,766 non-statutory stock options on September 30, 2026, as compensation for director services during the quarter ended September 30, 2026. Granted under the Amended and Restated 2021 Equity Incentive Plan and the non-employee director compensation policy, the options were immediately vested and exercisable, carry a $3.55 per-share exercise price, and expire September 29, 2036. His reported option holdings following the grant were 3,766 options.

Insider Trade Summary

Grant/Award: 3,766 shares

Grant/Award 1 txn

Insider Basenese Lou

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Non-Statutory Stock Options F1	3,766	$0.00	$0.00

Holdings After Transaction: Non-Statutory Stock Options — 3,766 contracts (Direct)

Footnotes (1)

1. F1. As compensation for services as a non-employee director during the quarter ended September 30, 2026, the reporting person was granted non-statutory stock options to purchase 3,766 shares of common stock under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date.

Key Figures

Options granted: 3,766 options Reported option holdings after grant: 3,766 options Exercise price: $3.55 per share +1 more

4 metrics

Options granted 3,766 options Granted to Lou Basenese on September 30, 2026

Reported option holdings after grant 3,766 options Following the September 30, 2026 grant

Exercise price $3.55 per share Non-statutory stock options

Expiration date September 29, 2036 Non-statutory stock options

Key Terms

non-statutory stock options, vested, exercisable, Amended and Restated 2021 Equity Incentive Plan

4 terms

non-statutory stock options financial

"granted non-statutory stock options to purchase 3,766 shares"

Non-statutory stock options are a type of reward that companies give to employees, allowing them to buy company shares at a set price within a certain period. Unlike formal or government-approved plans, these options are more flexible but may have different tax implications. For investors, they can influence a company's stock price and financial health, making them an important factor to consider.

vested financial

"were immediately vested and exercisable on the grant date"

exercisable financial

"were immediately vested and exercisable on the grant date"

Amended and Restated 2021 Equity Incentive Plan financial

"under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did CLIR director Lou Basenese receive?

Lou Basenese, a ClearSign Technologies Corp director, received 3,766 non-statutory stock options on September 30, 2026, as compensation for director services during the quarter ended that day. His reported option holdings after the grant were 3,766 options.

When do CLIR director Lou Basenese’s options vest and expire?

The options were immediately vested and exercisable on the grant date, had a $3.55 per-share exercise price, and expire September 29, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 07:01 PM Accepted by SEC EDGAR 10/02/2026 - 07:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Basenese Lou

(Last) (First) (Middle)

8023 E. 63RD PLACE, SUITE 101

(Street)

TULSA OKLAHOMA 74133

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ClearSign Technologies Corp [ CLIR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Statutory Stock Options	$3.55	09/30/2026		A		3,766		(1)	09/29/2036	Common Stock	3,766	$0.00	3,766	D

Explanation of Responses:

1. As compensation for services as a non-employee director during the quarter ended September 30, 2026, the reporting person was granted non-statutory stock options to purchase 3,766 shares of common stock under the ClearSign Technologies Corporation Amended and Restated 2021 Equity Incentive Plan pursuant to the issuer's non-employee director compensation policy. These non-statutory stock options were immediately vested and exercisable on the grant date.

	/s/ Louis J. Basenese	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)